Activity Overview
This educational activity is an archive of the live conference held on July 11 – 12, 2026.
Target Audience
This educational activity is directed toward hematologists, medical oncologists, and fellows involved in the treatment and management of patients with hematologic malignancies. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of hematologic malignancies may also participate.
Learning Objectives
- Evaluate the efficacy and safety of approved and emerging therapies based on current clinical trial data
- Select appropriate initial therapy using clinical evidence, guidelines, and patient- and disease-specific factors (including biomarkers)
Barbara Pro, MD
Professor of Medicine, Division of Hematology
and Oncology
Columbia University Vagelos College of
Physicians and Surgeons
Clinical Director, Lymphoma Program
Herbert Irving Comprehensive Cancer Center
NewYork-Presbyterian/Columbia University
Irving Medical Center
New York, NY
Amer Zeidan, MD, MBBS
Professor of Internal Medicine (Hematology)
Chief, Division of Hematologic Malignancies
Yale School of Medicine
Yale Cancer Center
Smilow Cancer Hospital
New Haven, CT
Brandon DaSilva, MD
Clinical Fellow
Columbia University Irving Medical Center
New York, NY
Alessandra Ferrajoli, MD
Professor of Medicine
Deputy Chair, Department of Leukemia
Patient Safety and Quality Officer,
Department of Leukemia
Associate Medical Director, Leukemia Center
The University of Texas MD Anderson Cancer
Center
Houston, TX
Nicole Lamanna, MD
Judy Horrigan Professor of Medicine
Director, Chronic Lymphocytic Leukemia
Program
Chief, Leukemia Service
Herbert Irving Comprehensive Cancer Center
NewYork-Presbyterian/Columbia University
Medical Center
New York, NY
Marlise Luskin, MD, MSCE
Associate Program Director, Fellowship
Program
Educational Director, Adult Leukemia Program
Senior Physician
Dana-Farber Cancer Institute
Associate Professor of Medicine
Harvard Medical School
Boston, MA
Razan Mansour, MD
Clinical Fellow, Medical Oncology/Hematology
Yale School of Medicine
Smilow Cancer Center
New Haven, CT
Lourdes Mendez, MD, PhD
Assistant
Professor of Medicine
Yale
School of Medicine
New
Haven, CT
Alice Mims, MD
Professor of Internal Medicine
Co-Leader, Leukemia and Hematologic
Malignancies Research Program
Associate Director of Clinical Research for
Division of Hematology
Acute Leukemia and Myeloid Malignancies
Research Section Head for Division of
Hematology
The Ohio State University Comprehensive
Cancer Center – Arthur G. James
Cancer Hospital and Richard J. Solove
Research Institute
Columbus, OH
Maximilian Stahl, MD
Assistant Professor of Medicine
Yale School of Medicine
Director, Leukemia and Myeloid Malignancy
Program
Yale Cancer Center
New Haven, CT
Cristian Taborda, MD
Assistant Professor
Yale Cancer Center
Yale School of Medicine
New Haven, CT
Please click here to view disclosures for faculty and the staff of Physicians’ Education Resource®.
GET STARTED WITH THIS PROGRAM:
Register now to gain access to this program.
Create AccountAlready Registered? Login Here
